参考文献/References:
[1] Long NM, Rule DC, Zhu MJ, et al. Maternal obesity upregulates fatty acid and glucose transporters and increases expression of enzymes mediating fatty acid biosynthesis in fetal adipose tissue depots[J]. J Anim Sci,2012,90(7):2201-2210. DOI: 10.2527/jas.2011-4343.
[2] Ji C, Dai Y, Jiang W, et al. Postnatal overfeeding promotes early onset and exaggeration of high-fat diet-induced nonalcoholic fatty liver disease through disordered hepatic lipid metabolism in rats[J].J Nutr Biochem,2014, 25(11):1108-1116. DOI: 10.1016/j.jnutbio.2014.06.010.
[3] Chang CC, Yang MH, Tung HC, et al. Resveratrol exhibits differential protective effects on fast- and slow-twitch muscles in streptozotocin-induced diabetic rats[J]. J Diabetes,2014,6(1):60-67. DOI: 10.1111/1753-0407.12072.
[4] Kelly DM, Nettleship JE, Akhtar S, et al. Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice [J]. Life Sci, 2014,109(2):95-103. DOI: 10.1016/j.lfs.2014.06.007.
[5] Yao X, Hou S, Zhang D, et al. Regulation of fatty acid composition and lipid storage by thyroid hormone in mouse liver[J]. Cell Bio Sci, 2014,4:38. DOI: 10.1186/2045-3701-4-38.
[6] Lai CS, Liao SN, Tsai ML, et al. Calebin-A inhibits adipogenesis and hepatic steatosis in high-fat diet- induced obesity via activation of AMPK signaling[J]. Mol Nutr Food Res,2015,59(10):1883-1895. DOI: 10.1002/mnfr.201400809.
[7] Dieguez C, Fruhbeck G, Lopez M. Hypothalamic lipids and the regulation of energy homeostasis[J]. Obes Facts, 2009,2(2):126-135. DOI: 10.1159/000209251.
[8] Chan CY, Wei L, Castro-Munozledo F, et al.(-)-Epigallocatechin-3-gallate blocks 3T3-L1 adipose conversion by inhibition of cell proliferation and suppression of adipose phenotype expression[J]. Life Sci, 2011,89(21-22):779-785.DOI: 10.1016/j.lfs.2011.09.006.
[9] Zhang XH, Huang B, Choi SK, et al. Anti-obesity effect of resveratrol-amplified grape skin extracts on 3T3-L1 adipocytes differentiation[J]. Nutr Res Pract,2012,6(4):286-293.DOI: 10.4162/nrp.2012.6.4.286.
[10] Gomez-Zorita S, Fernandez-Quintela A, Macarulla MT, et al. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress[J]. Br J Nutr, 2012,107(2):202-210. DOI: 10.1017/s0007114511002753.
[11] Jeon BT, Heo RW, Shin HJ, et al. Attenuation by a Vigna nakashimae extract of nonalcoholic fatty liver disease in high-fat diet-fed mice[J]. Biosci Biotechnol Biochem,2014,78(3):482-489. DOI: 10.1080/09168451.2014.882753.
[12] Fullerton MD, Galic S, Marcinko K, et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin[J]. Nat Med,2013,19(12):1649-1654. DOI: 10.1038/nm.3372.
[13] Sundaresan A, Radhiga T, Pugalendi KV. Effect of ursolic acid and rosiglitazone combination on hepatic lipid accumulation in high fat diet-fed C57BL/6J mice[J]. Eur J Pharmacol, 2014,741:297-303.DOI: 10.1016/j.ejphar.2014.07.032.
[14] Videla LA, Fernandez V, Cornejo P, et al. T(3)-induced liver AMP-activated protein kinase signaling: redox dependency and upregulation of downstream targets[J]. World J Gastroenterol,2014,20(46):17416-17425.DOI: 10.3748/wjg.v20.i46.17416.
[15] Park S, Hwang IW, Makishima Y, et al. Spot14/Mig12 heterocomplex sequesters polymerization and restrains catalytic function of human acetyl-CoA carboxylase 2[J]. J Mol Recognit,2013,26(12):679-688.DOI:10.1002/jmr.2313.
[16] Chen QL, Luo Z, Shi X, et al. Dietary methimazole-induced hypothyroidism reduces hepatic lipid deposition by down-regulating lipogenesis and up-regulating lipolysis in Pelteobagrus fulvidraco[J]. Gen Comp Endocrinol, 2015,217-218:28-36. DOI: 10.1016/j.ygcen.2015.05.006.
[17] Zhang X, Song Y, Feng M, et al. Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver[J]. J Lipid Res, 2015,56(5):963-971.DOI: 10.1194/jlr.M047654.
[18] Lin Z, Zhang B, Liu X, et al. Effects of chicory inulin on serum metabolites of uric acid, lipids, glucose, and abdominal fat deposition in quails induced by purine-rich diets[J]. J Med Food, 2014,17(11):1214-1221.DOI: 10.1089/jmf.2013.2991.
[19] Gaunt ER, Cheung W, Richards JE, et al. Inhibition of rotavirus replication by downregulation of fatty acid synthesis[J]. J Gen Virol, 2013,94(Pt 6):1310-1317. DOI: 10.1099/vir.0.050146-0.
[20] Dossi CG, Tapia GS, Espinosa A, et al. Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: role of PPAR-alpha and SREBP-1c[J]. J Nutr Biochem, 2014,25(9):977-984. DOI: 10.1016/j.jnutbio.2014.04.011.
[21] Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis[J].Annu Rev Pathol,2010,5:145-171.DOI:10.1146/annurev-pathol-121808-102132.
[22] Jump DB, Torres-Gonzalez M, Olson LK. Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation[J]. Biochem Pharmacol,2011,81(5):649-660.DOI:10.1016/j.bcp.2010.12.014.
[23] Schreurs M, van Dijk TH, Gerding A, et al. Soraphen, an inhibitor of the acetyl-CoA carboxylase system, improves peripheral insulin sensitivity in mice fed a high-fat diet[J]. Diabetes Obes Metab,2009,11(10): 987-991.DOI:10.1111/j.1463-1326.2009.01078.x.
[24] Olsen AM, Eisenberg BL, Kuemmerle NB, et al. Fatty acid synthesis is a therapeutic target in human liposarcoma[J]. Int J Oncol, 2010,36(5):1309-1314.
[25] Mao J, DeMayo FJ, Li H, et al. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis[J]. Proc Natl Acad Sci U S A, 2006,103(22):8552-8557.DOI: 10.1073/pnas.0603115103.
[26] Olson DP, Pulinilkunnil T, Cline GW, et al. Gene knockout of Acc2 has little effect on body weight, fat mass, or food intake[J]. Proc Natl Acad Sci U S A,2010,107(16):7598-7603.DOI: 10.1073/pnas.0913492107.